Hyalofast and Nano Fractures in Osteochondral Lesions
SVOA Orthopaedics · 22.05.2026 · 6 (3) · 74-77
DOI: 10.58624/svoaor.2026.06.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift SVOA Orthopaedics, online erschienen am 22.05.2026. Verfasst von Lanzat Nicolas Federico und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Hyalofast was applied to a 42-year-old patient with an osteochondral lesion of the patella and medial femoral condyle of the left knee. Hyalofast was administered during knee arthroscopy. The patient was followed for one year and showed complete recovery, both in terms of imaging and symptoms. The efficacy and safety of Hyalofast in the treatment of osteochondral lesions of the knee were evaluated. Hyalofast's ability to promote cartilage regeneration and relieve pain was analyzed, comparing the results with other conventional treatments. The aim is to present and propose this treatment as a valid alternative for restoring joint integrity
Zitieren
APA
Federico, L. N., & Edilio, P. R. (2026). Hyalofast and Nano Fractures in Osteochondral Lesions. SVOA Orthopaedics, 6(3), 74-77. https://doi.org/10.58624/svoaor.2026.06.010
Vancouver
Federico LN, Edilio PR. Hyalofast and Nano Fractures in Osteochondral Lesions. SVOA Orthopaedics. 2026;6(3):74-77. doi:10.58624/svoaor.2026.06.010
BibTeX
@article{Federico2026,
author = {Federico, Lanzat Nicolas and Edilio, Paoletta Ruben},
title = {Hyalofast and Nano Fractures in Osteochondral Lesions},
journal = {SVOA Orthopaedics},
year = {2026},
volume = {6},
number = {3},
pages = {74--77},
doi = {10.58624/svoaor.2026.06.010}
}
EUVIMED